DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ye BD, Pesegova M, Alexeeva O. et al
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study.
Lancet 2019;
393: 1699-1707 . doi: 10.1016/S0140-6736(18)32196-2. Epub 2019 Mar 28
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.